Mortality Follow-Up and Analyses of Men in the MRFIT
|ClinicalTrials.gov Identifier: NCT00011206|
Recruitment Status : Completed
First Posted : February 13, 2001
Last Update Posted : March 17, 2014
|Condition or disease|
|Cardiovascular Diseases Heart Diseases Coronary Disease Myocardial Ischemia Diabetes Mellitus Cerebrovascular Accident Myocardial Infarction|
MRFIT was initiated in 1972 as a randomized, multicenter primary prevention trial designed to determine whether a special intervention consisting of smoking cessation, cholesterol reduction and control of high blood pressure, would result in a significant reduction in coronary heart disease (CHD) mortality, compared to usual care. Follow-up and analysis has continued on the 361,662 men screened and the 12,866 men randomized.
The National Death Index (NDI) will be used for continued follow-up of the MRFIT cohorts. An additional assay to establish IGF-1 and IGF binding protein will be added to the data set as a potential prognostic factor. The effort will focus on three primary aims related to long-term mortality. Aim 1 will relate nutritional-dietary data to twenty-five year mortality from coronary heart disease (CHD), stroke, cardiovascular disease (CVD), colon cancer, prostate cancer, and all causes for the 12,866 men randomized. Aim 2 will relate age, ethnicity, socioeconomic position, geographic location, major risk factors, low risk status, prior diabetes, and prior myocardial infarction to twenty-five year mortality for the 361,662 men screened. Aim 3 will relate insulin-like growth factor 1 (IGF-1), IGF binding protein, and fasting and one-hour glucose measurements from frozen baseline sera to mortality for the 12,866 men randomized.
|Study Type :||Observational|
|Study Start Date :||January 2001|
|Primary Completion Date :||June 2006|
|Study Completion Date :||June 2006|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00011206
|Principal Investigator:||James Neaton||University of Minnesota, MN|